To determine the accuracy of the Microlife WatchBP O3 blood pressure measuring device tested according to the requirements of the International Protocol of the European Society of Hypertension. The WatchBP O3 is designed to provide clinic, ambulatory, and self blood pressure (BP) measurements. Device evaluation was performed in 33 participants with a mean ± standard deviation age of 56.1 ± 20.7 years (range 30-95 years). Their systolic BP (SBP) was 144.7 ± 24.1 mmHg (range 90-180 mmHg), diastolic BP (DBP) was 86.8 ± 18.3 mmHg (range 50-120 mmHg), and arm circumference was 28.1 ± 2.9 cm (range 22.0-34.0 cm). Blood pressure measurements were performed in the sitting position. The WatchBP O3 passed all three phases of the European Society of Hypertension protocol for SBP and DBP. Mean blood pressure differences for the WatchBP O3 (device observer) were -1.7 ± 6.9 mmHg for SBP and -1.1 ± 4.3 mmHg for DBP. 
Introduction
To obtain a careful assessment of an individual blood pressure (BP) profile, current international guidelines recommend repeated measurements of BP using the traditional sphygmomanometric technique, self-measurement of BP at home, and the use of ambulatory BP monitoring for some clinical conditions [1, 2] . This implies the use of a specific device in each setting and the production of several clinical reports. Mercury is progressively being banned in several European countries [3, 4] and a modern approach is to abandon the auscultatory technique and use electronic devices for clinical BP assessment as well. Recently, the Microlife Company (Microlife AG, Widnau, Switzerland) produced the WatchBP O3, a device provided with three different function modes for clinic, home, and ambulatory BP measurement. The aim of this study was to verify the accuracy and reliability of this device according to the recommendations of the International Protocol of the European Society of Hypertension (ESH) [5] .
Methods

Participants
We evaluated the WatchBP O3 in 33 adult participants (18 women) with a mean ± standard deviation (SD) age of 56.1 ± 20.7 years (range 30-95 years). Their systolic BP (SBP) was 144.7 ± 24.1 mmHg (range 90-180 mmHg), diastolic BP (DBP) was 86.8 ± 18.3 mmHg (range 50-120 mmHg), and arm circumference was 28.1 ± 2.9 cm (range 22.0-34.0 cm). Blood pressure measurements were performed in the sitting position. Twenty-five participants were excluded because BP ranges were complete (n = 23), Korotkoff sounds were of poor quality (n = 1), or there was atrial fibrillation (n = 1). The study was approved by the Ethics Committee of the University of Padua, and written informed consent was given by the participants.
Device
The WatchBP O3 is a fully automated monitor that measures BP at the upper arm using the oscillometric technique. The device offers three measurement modes for clinic, home, or ambulatory BP. The proper operational mode can be selected using a switch on the side of the device. In the 'ambulatory' mode, the device takes measurement at fixed intervals of 15, 20, 30, or 60 min, as programmed by the physician. In the 'home' mode, the patient is assumed to take measurements in accordance with the recommendations of the ESH [6] , collecting a double measurement in the morning and the evening for 7 consecutive working days. When measurements have been carried out for the full 7-day period, a symbol will flash on the screen and the patient is invited to return to the clinic. In the 'casual' mode, the device functions as a regular automatic monitor and the stored readings can be reviewed by the physician at a later date.
The cuffs provided by the manufacturer are suitable for arm circumferences ranging from 22 to 42 cm. Other characteristics of the device are reported in the Appendix.
Device validation
The validation team consisted of three persons. The two observers used for the present validation (FR and FS) had received adequate training by an expert in BP measurement. They were tested according to the suggestions of the ESH protocol and the agreement between the two observers was 0.4 ± 2.0 mmHg for SBP and 0.2 ± 2.6 mmHg for DBP. Device evaluation was performed according to the ESH protocol [5] . Sequential same-arm measurements were performed with the participant in the sitting position. The two observers took BP measurement with a mercury sphygmomanometer at the upper arm using an adult cuff, the bladder of which covered at least 80% of the arm circumference. Four sequential readings were taken by observers 1 and 2 (BP1, BP3, BP5, and BP7), and three BP readings were taken by the supervisor with the test instrument (BP2, BP4, and BP6). The discrepancy 
DBP, diastolic blood pressure; SBP, systolic blood pressure. between the reading provided by the sphygmomanometer and the mean of observers' measurements was allocated in four zones of accuracy following the recommendations of the ESH protocol [5] . Pearson's test was used for correlations and Bonferroni correction was used to compute statistical significance. A P value of less than 0.05 or less was considered statistically significant.
Results
In the first phase, 15 participants (seven women) were assessed and five participants had their SBP and DBP in each of the three BP ranges required by the ESH protocol. In total, 45 measurements (three measurements Â 15 participants) were available for analysis. The results were in concordance with the requested criteria of the International Protocol for the primary phase (Table 1 ). In addition, the second phase encompassing 18 participants (11 women) was successfully completed, including the second part of phase 2 (phase 2.2) of the ESH protocol (Table 1 ). In total, 99 readings (three measurements Â 33 participants) were obtained. Mean differences ± SD between the WatchBP O3 and the observer were -1.7 ± 6.9 mmHg for SBP and -1.1 ± 4.3 mmHg for DBP (Fig. 1) . Visual inspection of the graphs shows that the device tended to underestimate BP at the upper extreme of the BP distribution. Indeed, a significant correlation was found between the BP discrepancies and the participants' DBP (P < 0.001). The correlation was of borderline significance for SBP (P = 0.07).
Discussion
These results provide information on the accuracy of the Microlife WatchBP O3 device, which allows assessment of BP in three different settings. The study showed that the device passed all the validation requirements of the ESH protocol [5] . In addition, the SDs of the device-observer differences were within the AAMI requirement of a SD of less than 8 mmHg [7] . In this study, we observed a tendency for the device to slightly underestimate BP obtained with the mercury sphygmomanometer, especially in participants with high BP at entry. A similar trend has been observed with most noninvasive devices [8, 9] and the overall results fulfilled the validation criteria of the ESH protocol.
The design of this device seems to be particularly useful for a modern and comprehensive approach to the patient with high BP. The WatchBP O3 is provided with three operational modes for clinic, home, and ambulatory measurements. The home mode is designed to collect BP readings in accordance with the recent recommendations of the ESH according to which home BP should be monitored for 7 days, with at least two morning and two evening measurements [6] . This monitoring schedule is useful for deciding on whether to start antihypertensive treatment or for evaluating the effect of therapeutic adjustments. When BP is controlled, the device can be programmed for long-term monitoring according to a more flexible schedule. Obviously, this device should be used under strict medical supervision.
We conclude that the Microlife WatchBP O3 is an accurate device that can provide a thorough assessment of the patient's BP profile in clinical practice.
Further cuff sizes are available as accessories.
Two hundred and fifty data memory with date and time for casual and ambulatory mode.
Dimensions
Width 80 Â Height 115 Â Diameter 35 mm.
Weight: 260 g, including batteries.
List of components Device including
Cuffs: WatchBP O3 D ring (medium size, 240 Â 133 mm bladder), (large size, 300 Â 145 mm bladder), washable, cuff plugs (for sealing during washing).
Power: 4 Â AAA size batteries.
Wearing accessory: pouch, straps, tube holder, 50 cm tube Â 1, 100 cm tube Â 1, shoulder strip, waist belt, shoulder sling, and anchor strip.
Documents: quick guide, patient diary, and instruction manual.
Software: WatchBP O3 Analyzer software.
Costs
Retail price around h700 -in Europe.
Compliance with standard
Class IIa medical device after European MDD 93/42 EEC + amendments.
Applicable standards for performance and safety. These are reported in detail in the instruction manual.
Power supply 4 Â 1.5 V batteries; size AAA.
Service facilities
Microlife distributors -refer to www.microlife.com or Microlife European Headquarter: Microlife WatchBP AG, Espenstrasse 139, CH 9443, Widnau, Switzerland.
Method of blood pressure measurement
Oscillometric, corresponding to Korotkoff method: phase I systolic, phase V diastolic.
Factors affecting accuracy
Movement artefacts, arrhythmias.
Operator training requirements
Users should follow the recommendations and instructions in the supplied manual. The monitor does not require specific expertize because it is very easy to operate.
